Intermediate-dose cytarabine is an effective therapy for adults with non-Langerhans cell histiocytosis

Overview of attention for article published in Orphanet Journal of Rare Diseases, February 2022

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 20,334 followers.

RT @dazzle4rare: Intermediate-dose cytarabine is an effective therapy for adults with non-Langerhans cell histiocytosis https://t.co/LAMP3p…

Intermediate-dose cytarabine is an effective therapy for adults with non-Langerhans cell histiocytosis https://t.co/LAMP3pPRrG

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.